XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
D
D

DaVita

뉴스

Reuters - 17 시간 전

U.S. STOCKS Morgan Stanley, Datadog, Berkshire Hathaway

BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Datadog, Berkshire Hathaway Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street jumped in upbeat trading on Monday, on a greater chance of presidential candidate Donald Trump winning a second term after surviving an assassination attempt, while interest-rate cut hopes also aided market sentiment.
A
A
C
G
T
U
U
D
Reuters - 18 시간 전

DaVita falls on report of FTC launching an investigation into co

BUZZ-DaVita falls on report of FTC launching an investigation into co ** Shares of dialysis firm DaVita DVA.N fall 2.8% to $137.59 ** The U.S. Federal Trade Commission is investigating DVA and Fresenius Medical Carev FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday ** The F
F
D
Reuters - 3 일 전

US FTC probing DaVita, Fresenius Medical, Politico reports

UPDATE 1-US FTC probing DaVita, Fresenius Medical, Politico reports Adds more details in paragraph 4, background in paragraph 6 July 13 (Reuters) - The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita DVA.N and Fresenius Medical Care FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.
F
D
Reuters - 3 일 전

US Federal Trade Commission Is Investigating Dialysis Providers Davita And Fresenius Medical Care- Politico

BRIEF-US Federal Trade Commission Is Investigating Dialysis Providers Davita And Fresenius Medical Care- Politico July 13 (Reuters) - US FEDERAL TRADE COMMISSION IS INVESTIGATING DIALYSIS PROVIDERS DAVITA AND FRESENIUS MEDICAL CARE- POLITICO Source https://tinyurl.com/ym3t3yby
F
D
Reuters - 3 일 전

US FTC probing DaVita, Fresenius Medical, Politico reports

US FTC probing DaVita, Fresenius Medical, Politico reports July 13 (Reuters) - The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita DVA.N and Fresenius Medical Care FMEG.DE over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.
F
D
Reuters - 1 달 전

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

BRIEF-Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase June 6 (Reuters) - DaVita Inc DVA.N : NUWELLIS AND DAVITA EXTEND SUPPLY AND COLLABORATION AGREEMENT PILOT PHASE NUWELLIS INC - EXTENSION OF ITS PILOT PHASE UNDER SUPPLY AND COLLABORATION AGREEMENT WITH DAVITA INC. UNTIL AUGUST 31 Source text for Eikon: ID:nGNXt5rsk Furt
D
Reuters - 2 달 전

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change NVIDIA Corp NVDA.OQ +7.0% Ralph Lauren Corp RL.N +4.1% Vistra Corp VST.N +3.7% Freeport-McMoRan Inc FCX.N +3.6% DaVita Inc DVA.N +3.5% Bottom Performers Percent Change Moderna Inc MRNA.OQ -8.8% Builders FirstSource Inc BLDR.N -5.3% Mar
N
U
F
D
M
P
Reuters - 2 달 전

U.S. Altus Power, Home Depot, Jack in the Box

U.S. RESEARCH ROUNDUP-Altus Power, Home Depot, Jack in the Box May 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Altus Power, Home Depot and Jack in the Box, on Wednesday. HIGHLIGHTS * Altus Power Inc AMPS.N : JP Morgan cuts to neutral from overweight * Cheniere Energy Inc LNG.N : RBC cuts target price to $198 from $200 * Dick's Sporting Goods Inc DKS.N : Jefferies raises target price to $212 from $211 * Home De
C
D
A
D
Reuters - 3 달 전

DaVita Inc reports results for the quarter ended in March - Earnings Summary

DaVita Inc reports results for the quarter ended in March - Earnings Summary DaVita Inc DVA.N reported quarterly adjusted earnings of $2.26​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of $1.25. The mean expectation of six analysts for the quarter was for earnings of $1.95 per share.
D
Reuters - 3 달 전

DaVita gains after upbeat quarterly profit prompts annual forecast raise

DaVita gains after upbeat quarterly profit prompts annual forecast raise May 2 (Reuters) - DaVita DVA.N raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell. The healthcare services provider raised the lower end of its 2024 adjusted per share profit forecast range by 30 cents to $9, while keeping the higher end intact at $9.80. Analysts on average estimate an annual profit of $9.01 per share,
D
Reuters - 3 달 전

DaVita Q1 EPS USD 2.65

BRIEF-DaVita Q1 EPS USD 2.65 May 02 (Reuters) - DaVita Q1 operating income USD 484 million. Q1 adjusted operating income USD 463 million vs. IBES estimate USD 418.9 million Q1 adjusted EPS USD 2.38 vs. IBES estimate USD 1.95
D
Reuters - 3 달 전

Fed QT taper calms the horses, yen pops again

MORNING BID AMERICAS-Fed QT taper calms the horses, yen pops again A look at the day ahead in U.S. and global markets from Mike Dolan Anxious bond traders seem to have taken solace from the Federal Reserve's surprisingly sharp brake on its "quantitative tightening" process on Wednesday, while the yen capitalized on an easier dollar after what seemed like the second bout of Japanese intervention this week.
A
A
A
C
E
H
I
R
S
U
A
U
I
V
W
Z
A
B
D
H
I
L
P
P
P
T
Reuters - 3 달 전

DaVita Inc <DVA.N> expected to post earnings of $1.95 a share - Earnings Preview

DaVita Inc expected to post earnings of $1.95 a share - Earnings Preview DaVita Inc DVA.N , DVA is expected to show a rise in quarterly revenue when it reports results on May 2 for the period ending March 31 2024 The Denver Colorado-based company is expected to report a 5.4% increase in revenue to $3.028 billion from $2.87 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
D
Reuters - 3 달 전

Acciona Energia Signs Renewable PPA With DaVita In Spain

BRIEF-Acciona Energia Signs Renewable PPA With DaVita In Spain April 24 (Reuters) - Corporacion Acciona Energias Renovables SA ANE.MC : SIGNS RENEWABLE PPA WITH DAVITA IN SPAIN PPA FOR 12 YEARS ELECTRICITY WILL COME FROM AYORA I-II-III PHOTOVOLTAIC COMPLEX (85.74 MWP), CURRENTLY UNDER DEVELOPMENT IN VALENCIA, WHICH WILL COME INTO OPERATION IN 2025
D
Reuters - 3 달 전

U.S. STOCKS WiSA Technologies, Rivian Automotive, Cigna Group

BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities, though the blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth.
C
W
T
U
U
A
D
S
Reuters - 3 달 전

U.S. STOCKS Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals

BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals The Dow Jones Industrial Average outshone its peers on Tuesday following upbeat results from health insurer UnitedHealth, while higher Treasury yields and conflict in the Middle East kept investors on edge. .N At 11:02 ET, the Dow Jones Industrial Avera
C
H
N
T
W
R
T
U
U
A
D
L
S

조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.